Home › Graves Disease › Missouri
Graves Disease clinical trials in Missouri
3 studies for Graves Disease are looking for participants at sites in Missouri.
Cities in Missouri
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Truman Medical Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-004, Kansas City
- Site-015, St Louis
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1033, Jefferson City
- Site Number - 1004, Kansas City
- Site Number - 1019, St Louis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.